Israeli Stock Market Faces Potential Bubble Amid Global Tech Surge
The Israeli stock market, mirroring global trends, is experiencing a significant surge, particularly in technology and chip-related stocks, with Intel and ARM seeing a 13% jump. This rally occurs despite concerns over high oil prices, the potential for AI investments to lack returns, and rising interest rates. Analysts describe the market sentiment as a "herd mentality" or "euphoria," with a large influx of capital from both institutional and private investors who anticipate the continuation of this upward trend.
However, the article warns of a potential market bubble, drawing parallels to the late 1990s tech boom that preceded a major crash. It notes that those who might benefit from the bubble, such as government officials, treasury departments, and investment firms, are unlikely to publicly acknowledge the risk. The piece advises investors to consider defensive strategies, even if they wish to remain in the stock market, by seeking out stocks with reasonable valuations and those less susceptible to economic downturns.
Examples of defensive stock types include those with substantial cash reserves, undervalued stocks not held by "weak hands," and value stocks that are currently overlooked due to the focus on technology, AI, and chips. Commodity stocks, despite recent underperformance, are highlighted as potentially offering good value, as are pharmaceutical stocks. The article also points to companies trading below their net current asset value as a potential investment, citing Globrandas as an example of a company facing challenges but potentially resilient due to its valuation.
Dual-listed Israeli stocks are expected to benefit from positive arbitrage gaps following Wall Street's gains, with Tower Semiconductor specifically mentioned. The article also touches upon the performance of specific Israeli stocks, noting that while the banking sector saw a slight decline, the Tel Aviv 35 index closed higher, with companies like Nice and Mega Or showing significant gains. Teva Pharmaceutical Industries is also predicted to rise.
